Surgery – Diagnostic testing – Detecting nuclear – electromagnetic – or ultrasonic radiation
Reexamination Certificate
2005-05-24
2005-05-24
Casler, Brian L. (Department: 3737)
Surgery
Diagnostic testing
Detecting nuclear, electromagnetic, or ultrasonic radiation
C600S407000, C600S410000, C600S419000, C324S300000
Reexamination Certificate
active
06898455
ABSTRACT:
A method for treating attention deficit/hyperactivity disorder (ADHD) includes performing an objective ADHD behavioral assay for a patient, administering a drug to the patient at varying doses, and performing an fMRI on the patient for the varying drug doses to determine an optimal dosage for the patient. The method can further include performing a further objective ADHD behavioral assay after the drug administration.
REFERENCES:
patent: 4421122 (1983-12-01), Duffy
patent: 4435449 (1984-03-01), Stern
patent: 4502007 (1985-02-01), Mee et al.
patent: 5068610 (1991-11-01), Mehlkopf et al.
patent: 5142231 (1992-08-01), Jensen et al.
patent: 5270651 (1993-12-01), Wehrli
patent: 5307015 (1994-04-01), Kaufman et al.
patent: 5377100 (1994-12-01), Pope et al.
patent: 5655531 (1997-08-01), Nishimura et al.
patent: 5658590 (1997-08-01), Heiligenstein et al.
patent: 5671741 (1997-09-01), Lang et al.
patent: 5682883 (1997-11-01), Fiat
patent: 5696168 (1997-12-01), Heiligenstein et al.
patent: 5817656 (1998-10-01), Beasley, Jr. et al.
patent: 6258032 (2001-07-01), Hammesfahr
patent: 6400978 (2002-06-01), Teicher et al.
Yufeng Zang, et al., “Objective Measurement of the Balance Dysfunction in Attention Deficit Hyperactivity Disorder Children”, Chinese Journal of Clinical Rehabilitation, May 2002, vol. 6, No. 9, pp. 1372-1374.
“Attention-Deficit/Hyperactivity Disorder (ADHD): Prominent Striatal Abnormalities Revealed by Steady-State (MRI Relaxometry”, M.H. Teicher et al., Abstract cited in Society for Neuroscience, vol. 24, 1998, paragraph 484.13, pp. 1238.
Dose-Dependent Effects of Methylphenidate on Activity, Attention, and Magnetic Resonance Measures in Children with ADHD, M.H. Teicher et al., Abstract cited in Society for Neuroscience, vol. 22, 1996, paragraph 468.3, pp. 1191.
“Methylphenidate Dose-Dependently Decreases Blood Flow in the Cerebellar Vermis of Children with ADHD”, C. M. Anderson et al., McLean Hospital, Belmont, MA, NCDEU, poster presentation, June 1999.
“Dose-Dependent Effects of Methylphenidate on Activity, Attention, and Magnetic Resonance Meausres in Children with ADHD”, M. H. Teicher et al., McLean Hospital, Belmont, MA, poster presentation, Nov. 1998.
C. M. Anderson et al., “Childhood Abuse: Limbic System Checklist-33 and Cerebellar Vermis Blood Flow”, Harvard Med. Sch., Developmental Biopsychiatry Research Program & The Brain Imaging Center, McLean Hospital, Belmont, MA, NR:384.
C. M. Anderson et al., “Cerebellar Vermis Blood Flow: Associations with Psychiatric Symptoms in Child Abuse and ADHD”, Harvard Med. Sch., Developmental Biopsychiatry Research Program & The Brain Imaging Center, McLean Hospital, Belmont, MA, 655.4.
C. M. Anderson et al., Methylphenidate Dose—Dependently Decreases Blood Flow in the Cerebellar Vermis of Children with ADHD, Harvard Med. Sch., Developmental Biopsychiatry Research Program & The Brain Imaging Center, McLean Hosptial, Belmont, MA.
Jessie C. Anderson et al., “DSM-III Disorders in Preadolescent Children”, Arch Gen Psychiatry, vol. 44, Jan. 1987, pp.69-76.
Hector R. Bird, et al., “Estimates of the Prevalence of Childhood Maladjustment in a Community Survey in Puerto Rico”, Arch Gen Psychiatry, vol. 45, Dec.1998,pp. 1120-1126.
Peter Szatmari et al., “Ontario Child Health Study: Prevalence of Attention Deficit Disorder with Hyperactivity”, Child Psychol. Psychiat. vol. 30, No. 2, 1989, pp. 219-230.
Russell A. Barkley, Ph.D., “A Critique of Current Diagnostic Criteria for Attention Deficit Hyperactiivity Disorder: Clinical and Research Implications”, Developmental and Behavioral Pediatrics, vol. 11, No. 6, Dec. 1990, pp. 343-352.
Warren W. Tryon, “The Role of Motor Excess and Instrumented Activity Measurement in Attention Deficit Hyperactivity Disorder”, Behavior Modification, vol. 17, No. 4, Oct. 1993, pp. 371-406.
Helen Orvaschel, Ph.D., Schedule for Affective Disorder and Schizophrenia for School-Age Children Epidemiologic Version, Kiddie-SADS-E (K-SADS-E), Orvaschel & Puig-Antich, Fifth Revision, Feb. 1994, pp. 1-128.
S. Ogawa et al., “On The Characteristics Of Functional Magnetic Resonance Imaging Of The Brain”, Annu. Rev. Biophys. Biomol. Struct. 1998. 27 pp 447-474.
Linus Pauling et al., “The Magnetic Properties And Structure Of Hemoglobin, Oxyhemoglobin And Carbonmonoxyhemoglobin”, Chemistry: Pauling and Coryell, vol. 22, Mar. 1936, pp. 210-216.
M. H. Teicher et al., “Attention-Deficit/Hyperactviity Disorder (ADHD): Prominent Striatal Abnormalitites Revealed by Steady-State fMRI Relaxometry”, Developmental Biopsychiatry Research Program and Neuroimaging Center, McLean Hospital, Belmont, MA, NR:384.
Seymour S. Kety, “Measurement of Local Blood Flow By The Exchange Of An Inert, Diffusible Substance”, Peripheral Blood Flow Measurement , Methods in Medical Research, vol. 8, 1960, pp. 228-235.
Peter C.M. van Zijl et al., “Quantitative Assessment of Blood Flow, Blood Volume And Blood Oxygenation Effects In Functional Magnetic Resonance Imaging”, Nature Medicine, vol. 4, No. 2, Feb. 1998, pp. 159-167.
Mark A. Goldberg et al., “Value of T1 and T2 Relaxation Times From Echoplanar MR Imaging In The Characterization Of Focal Hepatic Lesions”, AJR 1993; 160 pp. 1011-1017.
Hans C. Lou et al., “Focal Cerebral Hypoperfusion In Children With Dysphasia And/Or Attention Deficit Disorder”, Arch Neurol, vol. 41, Aug 1984, pp. 825-829.
Hans C. Lou et al., “Striatal Dysfunction In Attention Deficit And Hyperkinetic Disorder”, Arch Neurol, vol. 46, Jan. 1989, pp. 48-52.
Monique Ernst, et al., “Reduced Brain Metabolism In Hyperactive Girls”, J. Am. Acad. Child Adolesc. Psychiatry, 33:6, Jul./Aug. 1994, pp. 858-868.
Monique Ernst, et al., “DOPA Decarboxylase Activity In Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18] Fluorodopa Positron Emission Tomographic Study”, The Journal of Neuroscience, Aug. 1, 1998, 18(15), pp. 5901-5907.
Ann M. Graybiel, et al., “The Basal Ganglia And Adaptive Motor Control”, Science, vol. 265, Sep. 23, 1994, pp. 1826-1830
Chandan J. Vaidya et al., “Selective Effects Of Methylphenidate In Attention Deficit Hyperactivity Disorder: A Functional Magnetic Resonance Study”, Proc. Natl Acad. Sci. vol. 95, Nov. 1998, pp. 14494-14499.
Nora D. Volkow et al., “Effects of Methylphenidate On Regional Brain Glucose Metabolism In Humans: Relationship To Dopamine D2Receptors”, Am J Psychiatry 154:1, Jan. 1997, pp. 50-55.
Martin H. Teicher, et al., “Objective Measurement of Hyperactivity and Attentional Problems in ADHD”, J. Am. Acad. Child Adolesc. Psychiatry, 35:3, Mar. 1996, pp. 334-342.
Martin P. Paulus et al., “The Effects of MDMA and Other Methylenedioxy-Substituted Phenylalkylamines on the Structure of Rat Locomotor Activity”, Neuropsychopharmacology 1992, vol. 7, No. 1, pp. 15-31.
Luis C. Maas, et al., “Decoupled Automated Rotational and Translational Registration for Functional MRI Time Series Data: The DART Registration Algorithm”, MRM 1997, 37, pp. 131-139.
“Society of Magnetic Resonance in Medicine”; Book of Abstracts, vol. I; Tenth Annual Scientific Meeting and Exhibition; Aug. 10-16, 1991; San Francisco, CA; pp.107.
Anderson Carl M.
Lowen Steven Bradley
Maas, III Luis C.
Renshaw Perry F.
Teicher Martin H.
Casler Brian L.
Daly, Crowley & Mofford & Durkee, LLP
Jung William
The McLean Hospital Corporation
LandOfFree
Method for providing optimal drug dosage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for providing optimal drug dosage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for providing optimal drug dosage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3409065